Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis
1. The co-primary endpoints at weeks 2 and 4 were significantly greater with abrocitinib than...
Read More
Search Results for: atopic dermatitis
Abrocitinib Safety in Moderate-to-severe Atopic Dermatitis Adults After Switching from Dupilumab
Phase 3 trials have not yet evaluated the effectiveness of abrocitinib in patients with...
Read MoreAtopic Dermatitis in Children: Assessing the Impact of Height, BMI & Weight
Atopic dermatitis (AD) usually presents during childhood and is associated with itch and sleep disturbances. The onset of AD often occurs during the first 6 months of life, and most cases are seen before patients reach the age...
Read More
Factors Determining Severity of Atopic Dermatitis Observed
Knowledge of clinical signs and patient characteristics with severe AD can help physicians...
Read More
Atopic Dermatitis & Sleep Assessment: The SPINDLE Study
Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder in childhood. Sleep...
Read More